NCT Number: NCT01223950
Monitoring the Prevalence of E.R Admissions and Hospitalizations as a Result of Drug Related Problems (DRPs)
To research the prevalence and nature of DRP (Drug Related Problems) associated hospitalizations (hospitalizations due to problems\\adverse effects of the medication treatment) .
Analyzing the main reasons for DRP associated E.R admissions\\hospitalizations. identifying drug involved and percentage of DRP associated hospitalizations.
Monitoring the length of DRP associated hospitalizations. Evaluating LOS to hospitalized. Financial and other aspects will be measured.
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Possible DRP based on the current literature, patient questionnaire and drug history, related laboratories test values, ICD-9 coding.
Exclusion criteria
- DRP cannot be established or suspected based on the assessment of the patient's lab results, symptoms, drug treatment and patient's questioning as well as physician diagnosis
Sponsors and collaborators
Lead sponsor
Hillel Yaffe Medical Center
Other Gov
Collaborators
- Ben-Gurion University of the Negev
Registry information
Important dates
- Study start
- 2010
- Primary completion
- 2010
- First posted
- Oct 19, 2010
- Registry last updated
- Oct 19, 2010
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.